RxDoctor Payments Data

Sharon Kelly

Pediatric Dermatology · Bellevue, WANPI 1205930351

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $26,055 of the $37,593 with a category attached, or 69.3%. Pfizer accounts for 61.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $30,983 and has fallen 99.6% since, to $119 in 2025.

$37,593in general payments, 2019–2025

Across 320 payments — averaging $117.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$23K
  • Almirall LLC$8K
  • AbbVie$961
  • Novartis$901
  • Johnson & Johnson$878
  • UCB, Inc.$472
  • plus $3K from 14 others

What the payments were for

  • Consulting fees$8002%
  • Speaking & faculty fees$26,05569%
  • Travel & lodging$3,3439%
  • Food & beverage$7,20619%
  • Education$1891%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric dermatology providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole11$497

Paid to pharmacies, not to this prescriber.

Other pediatric dermatology in Bellevue

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →